Euphopubescenol and Euphopubescene, Two New Jatrophane Polyesters, and Lathyrane-type Diterpenes from Euphorbia pubescens

Abstract

The structures of euphopubescenol and euphopubescene, two new macrocyclic jatrophane diterpene polyesters, isolated from the whole dried plant of Euphorbia pubescens, were established as 5α,8α,15β-triacetoxy-3α-benzoyloxy-4α-hydroxy-9,14-dioxo-13βH-jatropha-6(17),11E-diene (1) and 3β,7β,8β,9α,14α,15β-hexaacetoxy-2βH-jatropha-5E,11E-diene (2) by 1D- and 2D-NMR (COSY, HMQC, HMBC and NOESY), IR, EI-MS and EI-FTICR-MS. Two known lathyrane derivatives, jolkinol A (3) and jolkinol A (4), whose ¹³C-NMR spectra were assigned, were also isolated. Compounds 1 - 3 have been evaluated for their ability to inhibit the in vitro growth of three human tumour cell lines representing different tumour types, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and SF-268 (CNS cancer). They inhibited both MCF-7 and NCI-H460 cell lines, with GI₅₀ values ranging between 40.9 μM and 95.3 μM, but were found to be ineffective as growth inhibitors of the SF-268 cell line.

Euphorbia pubescens - Euphorbiaceae - jatrophane diterpenes - antitumour activity

References

• 1 Appendino G, Jakupovic S, Tron G C, Jakupovic J, Milon V, Ballero M. Macrocyclic diterpenoids from Euphorbia semiperfoliata .  J Nat Prod. 1998;  61 749-56
• 2 Hartwell J L. Plants used against cancer. A survey.  Lloydia. 1969;  62 153-205
• 3 Yamamura S, Kosemura S, Ohba S, Ito M, Saito Y. The isolation and structures of euphoscopins A and B.  Tetrahedron Lett. 1981;  22 5315-8
• 4 Kupchan S M, Siegel C W, Matz M J, Gilmore C J, Bryan R F. Structure and stereochemistry of jatrophone, a novel macrocyclic diterpenoid tumour inhibitor.  J Am Chem Soc. 1976;  98 2295-300
• 5 Zheng W F, Cui Z, Zhu Q. Cytotoxic and antiviral activity of the compounds from Euphorbia kansui .  Planta Med. 1998;  64 754-6
• 6 Hohmann J, Molnár J, Rédei D, Evanics F, Forgo P, Kálmán A, Argay G, Szabó P. Discovery and biological evaluation of a new family of potent modulators of multidrug resistance: reversal of multidrug resistance of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from Euphorbia species .  J Med Chem. 2002;  45 2425-31
• 7 Lillehaug J R, Kleppe K, Sigel C W, Kupchan S M. Reaction of biological thiols with the tumour inhibitor jatrophone. Inhibition of RNA polymerase.  Biochim Biophys Acta. 1973;  327 92-100
• 8 Valente C, Ferreira M JU, Abreu P M, Pedro M, Cerqueira F, Nascimento M SJ. Three new jatrophane-type diterpenes from Euphorbia pubescens .  Planta Med. 2003;  69 361-6
• 9 Uemura D, Nobuhara K, Nakayma Y, Shizuri Y, Hirata Y. The structure of new lathyrane diterpenes, jolkinols A, B, C, and D, from Euphorbia jolkini Boiss.  Tetrahedron Lett. 1976;  17 4593-6
• 10 Adolf W, Hecker E, Becker H. Macrocyclic lathyrane type diterpene esters (jolkinols) from callus cultures and roots of Euphorbia lathyris .  Planta Med. 1984;  50 259-61
• 11 Jakupovic J, Morgenstern T, Bittner M, Silva M. Diterpenes from Euphorbia peplus .  Phytochemistry. 1998;  47 1601-9
• 12 Jakupovic J, Morgenstern T, Marco J A, Berendsohn W. Diterpenes from Euphorbia paralias .  Phytochemistry. 1998;  47 1611-9
• 13 Marco J A, Sanz-Cervera J F, Yuste A, Jakupovic J, Jeske F. Jatrophane derivatives and a rearranged jatrophane from Euphorbia terracina .  Phytochemistry. 1998;  47 1621-30
• 14 Sahai R, Rastogi R P, Jakupovic J, Bohlmann . A diterpene from Euphorbia maddeni .  Phytochemistry. 1981;  28 1665-7
• 15 Yamamura S, Yoshikazu S, Kosemura S, Ohtsuka J, Tayama T, Ohba S, Ito M, Saito Y, Terada Y. Diterpenes from Euphorbia helioscopia .  Phytochemistry. 1989;  28 3421-36
• 16 Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M. New colorimetric cytotoxicity assay for anticancer-drug screening.  J Natl Cancer I. 1991;  83 757-66
• 17 Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren J T, Bokesch H, Kenney S, Boyd M R. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumour cell lines.  J Natl Cancer Inst. 1990;  82 1107-12